Leerink Swann Starts Flamel Technologies (FLML) at Outperform

Go back to Leerink Swann Starts Flamel Technologies (FLML) at Outperform

Flamel Technologies (FLML) Updates on Unapproved Neostigmine Methylsulfate Manufacturers

August 4, 2014 7:19 AM EDT

Flamel Technologies (Nasdaq: FLML) has received communication from the U.S. Food and Drug Administration (FDA) that all manufacturers of unapproved versions of neostigmine methylsulfate have been notified by the FDA to cease manufacturing of the unapproved product as of July 30, 2014. Current inventory... More